Skip To Main Content
Rina Barouch-Bentov on Muck Rack

Rina Barouch-Bentov

As seen in: SAGE Publishing, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rina

Contact Rina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Clostridium cuniculi is associated with chronic high-morbidity low-mortality diarrhea in NSG and NSG-related mouse strains

|
By Kerriann Casey, Rina Barouch-Bentov, Wencke Reineking, Flavio H. Alonso
| SAGE Publishing
Get full access to this article View all access and purchase options for this article. References 1. Aranda-Díaz A, Ng KM, Thomsen T, et al. Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiota. Cell Host Microbe. 2022;30:260–272. 2. Armién AG, Polon R, Rejmanek D, et al.
Open in Who Shared Issue with article?

A 20-Gene Set Predictive of Progression to Severe Dengue

|
By Timothy E. Sweeney, Rina Barouch-Bentov, Makeda Robinson, Malaya Kumar Sahoo
| Cell Press Verified
Highlights • A multi-cohort analysis framework revealed a 20-gene set to predict severe dengue • The 20 genes effectively predict severe dengue in existing and prospective cohorts • The 20-gene set is generalizable across ages, host genetic factors, and virus strains • The 20-gene set has potential implications for the development of a prognostic assay Summary There is a need to identify biomarkers predictive of severe dengue.
Open in Who Shared Issue with article?

Turning Up Your Nose for a Flaviviral Encephalitis Cure

|
By Rina Barouch-Bentov, Shirit Einav
| Cell Press Verified
siRNA approaches have demonstrated promise in treating viral infections in animal models, but poor delivery limits clinical application. In this issue of Cell Host & Microbe, Beloor et al. (2018) report that nose-to-brain delivery of viral-targeted siRNA cures mice from West Nile virus encephalitis, with potential implications for human infection.
Open in Who Shared Issue with article?
See all 3 articles